---
schema_version: "secwatch.filing_event.v1"
accession: "0001798749-23-000045"
form_type: "8-K"
ticker: "JBIO"
cik: "0001798749"
company_name: "Jade Biosciences, Inc."
filed_at: "2023-06-21T23:59:59+00:00"
generated_at: "2026-06-13T20:11:33.933175+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aerovate raises $44.9M via ATM offering; cash runway into 2026

## Summary
- Sold 2,662,721 shares under ATM program for net proceeds of $44.9M.
- Total shares outstanding after transaction: 27,601,098.
- Cash, equivalents, and securities plus ATM proceeds fund operations into 2026 per management.

## SEC filing metadata
- accession: 0001798749-23-000045
- form_type: 8-K
- ticker: JBIO
- cik: 0001798749
- company_name: Jade Biosciences, Inc.
- filed_at: 2023-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1798749/000179874923000045/0001798749-23-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1798749/000179874923000045/tmb-20230621x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001798749-23-000045
- JSON: https://secwatch.observer/filing/0001798749-23-000045.json
- Plain text: https://secwatch.observer/filing/0001798749-23-000045.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.